Container-closure integrity (CCI) is a package’s ability to keep a drug product free from microbial ingress, content loss, and external contamination throughout its shelf life. The accepted benchmark is the maximum allowable leakage limit (MALL): for rigid sterile containers, a leak below 0.1 to 0.3 micrometers is treated as safe. CCI must be studied and verified across the entire product lifecycle, not just at release.
Why package sealing is a product quality problem, not a packaging detail
A pharmaceutical package does far more than hold the product. It protects against light, prevents solvent loss, blocks exposure to reactive gases such as oxygen, limits moisture pickup, and above all keeps a sterile product sterile. When the seal fails, the consequences are concrete: a vial that loses its headspace nitrogen can let oxygen degrade an oxygen-sensitive molecule, and a stopper that does not seat correctly can let bacteria reach a product that was sterile at fill.
For sterile products, seal integrity is directly tied to microbial safety. Regulators require that the sealing of sterile containers be validated so the product cannot be contaminated during its shelf life. The relevant science and expectations are captured in the United States Pharmacopeia chapter USP <1207>, which is organized into three sub-chapters: <1207.1> covers integrity testing across the product lifecycle including method selection and validation, <1207.2> covers leak detection technologies, and <1207.3> covers seal quality test technologies.
Sealing is a quality attribute of the product itself. It cannot be bolted on at the end with a final inspection.
What container-closure integrity actually means
Package integrity, also called container-closure integrity, is the ability of the packaging system to prevent product loss, microbial intrusion, and entry of harmful gas or other material, so that the drug keeps meeting its safety and quality requirements.
A container-closure integrity test (CCIT) detects any broken or leaking package. It can identify the size and sometimes the location of a leak. In practice, passing a CCIT usually means the package would pass a microbial challenge test.
The broader definition works better in practice: a package has good integrity when it has no leak that affects product quality. In other words, if the actual leak stays within the maximum allowable leakage limit (MALL), the package is considered sealed well enough.
MALL is the largest leak rate or leak size that is still acceptable. Below that limit, no leak exists that would harm the product. The package will keep its physical, chemical, and microbial properties during storage and use, including staying sterile, limiting loss of contents (including protective headspace gas), and blocking outside gases or substances.
It is not realistic to demand zero leakage. The real goal is risk-based: make sure any actual leak stays below the product’s MALL.
The three failure modes that matter
Looking at sterile products by risk, leaks fall into three types:
- Microbial ingress. A breach lets organisms in, which destroys the sterility attribute.
- Product escape or external liquid or solid intrusion. This changes the physical or chemical quality of the contents.
- Change in headspace gas composition or amount. This can alter stability or use, for example when protective nitrogen or vacuum is lost, or when oxygen, water vapor, or air enters.
These failure modes map to three quality requirement classes:
- Class 1: maintain sterility and composition, but headspace gas need not be maintained. The package must block content leakage and external liquid, solid, or microbial contamination.
- Class 2: maintain sterility, composition, and headspace gas together. On top of Class 1, the package must hold the headspace gas content or absolute pressure for physical and chemical stability.
- Class 3: multidose packages that must stay sterile. After opening, the product is accessed and used many times, so the package must keep blocking microbial ingress and leakage during use.
A product that needs headspace protection has a tighter MALL and may also need attention to the barrier properties of the packaging material itself.
Studying integrity across the full lifecycle
CCI work starts in development and continues through the whole lifecycle, including routine production and stability storage. It covers package design and selection, incoming component control, process control of sealing-critical parameters, method development and validation, and stability evaluation during shipping, storage, and use.
Treating CCI as a one-time test at release misses the point. It is a continuous quality confirmation that runs across three phases:
- Development and qualification
- Production
- Stability evaluation
Development and qualification
Package selection should start from the user requirement specification (URS): what the product demands of its package in terms of sterility, headspace maintenance, contents, process, stability, storage and distribution environment, and how the patient or user will finally handle it.
Early work on the seal system should cover component sourcing, physical specifications, component dimensions, and fit studies, plus an assessment of the supplier, so that an incoming specification for the package can be set.
The purpose of this phase is to use a reliable process, at defined operating parameters, to consistently make a product (including its package) that meets the URS. Sterile product sealing must be validated, and good sealing depends on the package, the product itself, and the manufacturing process, especially the sealing-critical parameters.
To prove the process is robust, teams simulate worst-case conditions. Examples include the highest sterilization temperature and frequency, or the extreme crimping pressure or sealing temperature. The exact conditions come from a combined assessment of package, product, and process. The evidence produced shows the seal holds even under the strictest expected conditions.
Production
Good CCI mostly comes from good design and good process control, not from online performance tests or final inspection alone. Not every seal defect is easy to detect, so no online or final test can replace control and monitoring of the sealing-critical parameters.
Process control is built on managing each unit operation, such as the time, temperature, and pressure of the sealing step. Leak and integrity testing should run continuously and accumulate data, so operations that harm the seal are caught and avoided.
If the package is well designed in development and the critical process is well controlled in production, the need for final-product integrity testing can be reduced. For packages where 100 percent online testing is possible and results sit at or below the MALL, no extra container integrity test is needed.
In general, CCI controls include leak detection, seal quality testing, and visual inspection, and these can be combined into a tailored control strategy. The chosen strategy depends heavily on the failure cases found during process validation and the data gathered in development.
Seal quality testing differs from leak detection. It does not directly prove the package is intact. Instead, it characterizes and monitors the quality of the seal parameters, such as confirming that material and component attributes and the assembly process stay within set standards, which supports the package’s ability to stay sealed.
Common seal quality tests include torque testing, package burst testing, seal strength testing (often called peel-force testing), and residual seal force (RSF) testing, with details in USP <1207.3>.
One caveat: a package can pass seal quality testing and still leak. A torque-compliant bottle can leak through a scratched (porous) surface. That is why a proper leak detection method is still needed to find actual leaks.
Stability evaluation
Integrity testing is recommended as part of the stability program for commercial products, as an alternative to sterility testing at intermediate time points. It does not replace sterility testing at release, and the first and last stability time points still require sterility testing. At other points, a passing integrity test can stand in for the sterility test.
For some products, sterility testing alone is not enough to confirm integrity. A product needing headspace protection can be proven free of microbial ingress yet still lose its headspace gas, so its quality requirement is not met. For these products, periodic verification using a suitable method may be needed, for example testing the headspace-holding ability of retained samples at set intervals.
Beyond the three phases, the lifecycle mindset applies to change. After approval, any change that could affect sealing, such as a new package material supplier or a different crimping or sealing machine, should trigger a re-assessment or re-validation of CCI. Where a validated integrity method cannot be used in commercial production, periodic verification based on product and quality-risk assessment is needed.
Choosing the right leak test method
An ideal integrity test detects the smallest unacceptable leak for a given package. In practice, no single method fits every package, and the best method for one package may not reach the required sensitivity.
For example, protein or salt in the contents can clog a leak path and interfere with gas-flow methods such as vacuum decay or mass extraction. Method suitability must be checked, and the chosen method must be validated to rule out interference between the product and the technique.
USP <1207.1> lists the main points for method selection:
| Selection factor | What to consider |
| Package contents | Liquid or solid contents, headspace gas |
| Design and materials | Rigid container versus flexible bag |
| Seal method and mechanism | Physical closure versus fusion or heat seal |
| MALL | The product’s maximum allowable leakage limit |
| Deterministic vs probabilistic | Prefer a deterministic method that detects the MALL |
| Physico-chemical vs microbial | Typically a physico-chemical method is preferred |
| Output form | Leak presence, leak location, or leak rate |
| Quantitative vs qualitative | Whether a number or a pass/fail is needed |
| Method detection limit | Smallest leak the method reliably sees |
| Method detection range | Smallest and largest leak size or rate it can measure |
| Non-destructive vs destructive | Whether the sample survives the test |
| Online vs offline | In-line testing versus laboratory testing |
Because packages and methods vary, CCI usually uses more than one method across the lifecycle. The requirement differs by stage: a fast online test that rejects broken or badly assembled packs does not need to reach the MALL, while release or stability testing does.
The preferred approach is a deterministic method (usually physico-chemical) that can detect the product’s MALL.
The numbers behind MALL
Research on rigid containers shows that a pore around 0.1 micrometer in diameter carries little risk of liquid leakage, while a pore of about 0.3 micrometer carries a risk of microbial ingress. A conservative MALL for rigid packaging is 6 x 10^-6 mbar x L x s^-1, which corresponds to a pore between 0.1 and 0.3 micrometer. Adopting this conservative MALL keeps microbial and liquid leak risk low, so no extra pore-sizing studies such as microbial or liquid challenge tests are needed.
When the MALL cannot be defined, as with flexible materials or complex long seals, or when the method cannot reach the 0.1 to 0.3 micrometer sensitivity, a second method (with microbial challenge recommended as one of them) is used for comparison.
For reference, microbial challenge and dye immersion methods sit at a theoretical detection limit that corresponds to a leak pore range of about 5 to 10 micrometers. These are theoretical limits, not fixed values, and actual numbers shift with package, instrument, method parameters, and sample preparation.
Validating the chosen method
Equipment confirmation first
Before method work, confirm the equipment: assess the instrument’s functions, and use appropriate calibration tools or standards to simulate leaks and test the analyzer’s detection capability.
Method validation
After equipment confirmation, validate the method with attention to detection limit (sensitivity), system suitability, and precision. Also consider how the method compares to microbial ingress risk and how negative and positive controls are set, so the method truly meets the product’s integrity requirements.
Detection limit
The detection limit is the smallest leak rate or size the method reliably detects. Using established principles, it is confirmed by repeat testing of packages with and without induced leaks, across multiple operators and days.
False negatives (missing a real leak) and false positives (calling an intact package leaking) both threaten small-leak detection. A trace-gas method may read gas passing through the container wall as a leak, giving a false positive. Conversely, a missing signal may be read as no leak, when in fact the path is blocked by air, product, or debris, which can make dye methods miss a small leak. Detection limit is therefore set by comparing packages with known leaks (positive controls) to those without (negative controls).
System suitability
System suitability matters for every method, especially probabilistic methods that are sensitive to many variables and need more challenge samples (both negative and positive controls).
Microbial ingress risk comparison
A deterministic method that detects the MALL is preferred. For rigid packages, the conservative 0.1 to 0.3 micrometer MALL keeps microbial and liquid risk low. If the test method’s detection limit is below the package MALL, meaning it can find leaks of 0.1 to 0.3 micrometer, no comparison with microbial challenge is needed during validation.
In most cases, though, the MALL is undefined or the method detection limit is well above 0.1 to 0.3 micrometer. Then a microbial challenge method is compared with the physico-chemical method to understand how detection ability relates to microbial ingress risk.
When running a microbial ingress risk study, remember that microbial challenge is a probabilistic method. A meaningful study uses many negative and positive controls spanning a series of leak sizes, and accounts for the many factors that can affect the result.
Negative and positive controls
A negative control is a container with no known leak. A positive control is a container with a deliberately made or known leak.
To understand how detection probability relates to pore size, positive controls spanning a range of pore sizes (for example 2, 5, 10, and 20 micrometer) are especially important for probabilistic methods. Controls should use normally processed components, assembled the same way as the test product, with the only difference being the intentional leak in the positive control.
Making the leak pores
Pore creation must respect how leak dynamics relate to pore type and material. Common approaches include drilling or breaking the wall (laser drilling, microtube or capillary insertion, wire embedding).
Laser drilling introduces no foreign material. On rigid glass or plastic it can make leaks as small as 2 to 3 micrometer, and on thick flexible material 5 to 10 micrometer. Laser holes are often irregular rather than straight, and they have different surfaces on each side, so the actual diameter should be measured.
Microtube (capillary) insertion seals a thin tube through the wall. Tubes can be cut to any length and narrowed to about 2 micrometer. They are often used in gas-flow methods to stand in for short small pores. But microbial ingress depends more on whether liquid fills the channel than on the inner diameter alone, so the real package situation should be mimicked.
Wire embedding places a fine wire or strip at the seal, or a perforated metal sheet on the surface. It is used for larger positive controls, good for feasibility studies or finding the upper range of a method. Be aware that foreign objects such as needles, strips, or wires can make gas, liquid, or microbial leak dynamics differ from reality.
Practical takeaways for your CCI program
- Start from the URS. Define what the product needs from its package before choosing materials or methods.
- Treat sealing as a process attribute. Control and monitor sealing-critical parameters continuously; do not rely on final inspection.
- Use worst-case simulation in qualification. Prove the seal holds at the most extreme validated operating conditions.
- Prefer a deterministic physico-chemical method that reaches the MALL for release and stability testing.
- Adopt the 0.1 to 0.3 micrometer conservative MALL for rigid containers to skip extra pore-sizing challenges, when justified.
- Combine controls into a tailored strategy. Leak detection, seal quality testing, and visual inspection can work together.
- Re-validate on change. A new supplier or new sealing machine should trigger a CCI re-assessment.
- Mind method interference. Check that product contents do not clog or mask the chosen detection technique.
Limitations to keep in mind
The detection limits quoted here for methods such as microbial challenge and dye immersion are theoretical values from published guidance, not fixed numbers for your product. Actual performance depends on the specific package, instrument, method settings, and how samples are prepared. Most products cannot define a precise MALL, especially flexible or complex seals, so comparative studies with microbial challenge are often required. Pore-making techniques introduce artifacts, and the dynamics of a laser hole or an embedded wire may not match a real defect. Every program should validate its own method and controls rather than borrow numbers.
Bottom line
Container-closure integrity is a product quality attribute that must be designed, controlled, validated, and monitored across the entire drug product lifecycle. Anchor your program to a risk-based MALL, prefer deterministic methods that reach it, validate with proper controls, and re-confirm whenever the package or process changes. Sterility at release is necessary but not sufficient; integrity is what keeps the product trustworthy on the shelf and in the patient’s hands.
Frequently asked questions
What is container-closure integrity (CCI)?
Container-closure integrity is the ability of a drug package to stop product loss, microbial intrusion, and entry of harmful gas or material, so the product keeps meeting its safety and quality needs through storage and use.
What does MALL mean in packaging?
MALL stands for maximum allowable leakage limit. It is the largest leak rate or size still considered safe. For rigid sterile containers, a conservative MALL of 0.1 to 0.3 micrometer pore size is widely used.
Why is container-closure integrity testing important for sterile drugs?
A failed seal can let bacteria reach a sterile product, let oxygen or moisture degrade the contents, or let protective headspace gas escape. Testing confirms the product stays safe and effective across its shelf life.
What is the difference between leak detection and seal quality testing?
Leak detection finds actual breaches in a finished package. Seal quality testing monitors the parameters of the seal, such as torque or seal strength, to support the ability to stay intact. A package can pass seal quality testing and still leak.
Which CCI method should I choose?
Prefer a deterministic physico-chemical method that can detect your product’s MALL. Match the method to contents, package design, seal mechanism, and lifecycle stage, and validate it to rule out product interference.
When can microbial challenge testing be skipped in validation?
For rigid containers using the conservative 0.1 to 0.3 micrometer MALL, if your test method’s detection limit is below that MALL, you usually do not need to compare against microbial challenge during validation.
Does passing release sterility testing mean the seal is fine?
No. Release sterility testing confirms the batch was sterile at that moment. It does not by itself confirm the seal will hold during storage, shipping, and use, which is why lifecycle integrity testing is required.
How should leak pores for positive controls be made?
Common methods are laser drilling, microtube or capillary insertion, and wire embedding. Each has artifacts, so measure the actual pore and mimic real package conditions as closely as possible.
Is container-closure integrity testing needed only at product release?
No. It should run across development, production, and stability, and be re-assessed when package materials, suppliers, or sealing equipment change after approval.
What are the main leak failure modes for sterile packages?
The three are microbial ingress, product escape or external liquid or solid intrusion, and change in headspace gas composition or amount. Each maps to different quality requirement classes.

Comments are closed